Skip to main content
logo
MAIA Biotechnology, Inc. (MAIA)
NYSEAMERICAN: MAIA · Real-Time Price · USD
1.360
+0.040 (3.03%)
Aug 4, 2026, 4:00 PM EDT - Market closed

MAIA Biotechnology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
8359522038-
Market Cap Growth
79.50%14.10%160.60%-48.32%--
Enterprise Value
48.2859.151.7912.7227.50
Last Close Price
1.361.531.981.173.51-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.9724.8714.2541.624.52-
P/TBV Ratio
1.7920.6812.0932.493.83-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
----14.97-1.29-1.15
Net Debt / EBITDA Ratio
---0.350.681.36
Net Debt / FCF Ratio
---0.550.912.57
Quick Ratio
-00.021.483.444.95
Current Ratio
5.591.662.651.533.614.97
Return on Equity (ROE)
-160.91%-745.24%-1131.02%-440.12%-178.30%-332.54%
Return on Assets (ROA)
-114.57%-244.41%-191.37%-206.06%-138.56%-128.98%
Return on Invested Capital (ROIC)
-156.95%-476.18%-535.94%-18618.20%-3724.20%-2267.98%
Return on Capital Employed (ROCE)
-156.95%-476.18%-378.72%-354.61%-180.39%-189.13%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-47.62%-44.68%-67.38%-42.95%-75.75%-19.23%
Total Shareholder Return
-47.62%-44.68%-67.38%-42.95%-75.75%-19.23%
SEC Filings: 10-K · 10-Q